| GSTM3 and GSTP1: novel players driving tumor progression in cervical cancer A Checa-Rojas, LF Delgadillo-Silva, M del Castillo Velasco-Herrera, ... Oncotarget 9 (31), 21696, 2018 | 38 | 2018 |
| Clinical evaluation of BRCA1/2 mutation in Mexican ovarian cancer patients D Gallardo-Rincón, RM Álvarez-Gómez, E Montes-Servín, ... Translational oncology 13 (2), 212-220, 2020 | 27 | 2020 |
| Ascites from ovarian cancer induces novel fucosylated proteins DR Alberto-Aguilar, VI Hernández-Ramírez, JC Osorio-Trujillo, ... Cancer Microenvironment 12, 181-195, 2019 | 13 | 2019 |
| The translational blocking of α5 and α6 integrin subunits affects migration and invasion, and increases sensitivity to carboplatin of SKOV-3 ovarian cancer cell line JC Villegas-Pineda, A Toledo-Leyva, JC Osorio-Trujillo, ... Experimental Cell Research 351 (2), 127-134, 2017 | 12 | 2017 |
| Effect of ovarian cancer ascites on SKOV-3 cells proteome: new proteins associated with aggressive phenotype in epithelial ovarian cancer A Toledo-Leyva, JC Villegas-Pineda, S Encarnación-Guevara, ... Proteome science 16, 1-12, 2018 | 10 | 2018 |
| Leishmania mexicana gp63 is the enzyme responsible for cyclooxygenase (COX) activity in this parasitic protozoa LA Estrada-Figueroa, JA Díaz-Gandarilla, VI Hernández-Ramírez, ... Biochimie 151, 73-84, 2018 | 9 | 2018 |
| PARP inhibitors in ovarian cancer: evidence for maintenance and treatment strategies A Bahena-González, A Toledo-Leyva, D Gallardo-Rincón Chinese Clinical Oncology 9 (4), 51-51, 2020 | 8 | 2020 |
| GSTM3 and GSTP1: novel players driving tumor progression in cervical cancer. Oncotarget 9, 21696–21714 A Checa-Rojas, LF Delgadillo-Silva, MDC Velasco-Herrera, ... | 6 | 2018 |
| Experiencia con el uso de olaparib en pacientes con cáncer de ovario D Gallardo-Rincón, G Alamilla-García, E Montes-Servín, ... Gaceta médica de México 155 (6), 585-589, 2019 | 5 | 2019 |
| PHD finger protein 20-like protein 1 (PHF20L1) in ovarian cancer: from its overexpression in tissue to its upregulation by the ascites microenvironment DR Alberto-Aguilar, VI Hernández-Ramírez, JC Osorio-Trujillo, ... Cancer Cell International 22 (1), 6, 2022 | 4 | 2022 |
| Validation of the QLQ-EN24 instrument for the assessment of health-related quality of life for women with endometrial cancer in México D Gallardo-Rincon, A Toledo-Leyva, A Bahena-Gonzalez, ... Archives of Gynecology and Obstetrics 304, 773-782, 2021 | 3 | 2021 |
| Validation of the Mexican-Spanish version of the EORTC QLQ-OV28 instrument for the assessment of quality of life in women with ovarian cancer D Gallardo-Rincon, A Toledo-Leyva, A Bahena-Gonzalez, ... Archives of Medical Research 51 (7), 690-699, 2020 | 2 | 2020 |
| Identificación de nuevas proteínas implicadas en el fenotipo agresivo del cáncer de ovario epitelial durante la inducción de la transición epitelio-mesenquimal por la ascitis A Toledo Leyva Tesis (DC)--Centro de Investigación y de Estudios Avanzados del IPN …, 2017 | 2 | 2017 |
| A monoclonal antibody against a Leishmania mexicana COX-like enzymatic activity also recognizes similar proteins in different protozoa of clinical importance VI Hernández-Ramírez, LA Estrada-Figueroa, Y Medina, ... Parasitology Research 122 (2), 479-492, 2023 | 1 | 2023 |
| Inducción de una molécula de~ 25 kDa por efecto del líquido ascítico en líneas celulares de cáncer de ovario A Toledo Leyva Tesis (MC)--Centro de Investigación y de Estudios Avanzados del IPN …, 2013 | 1 | 2013 |
| Overexpression of Fut 2, 4, and 8, and nuclear localization of Fut 4 in ovarian cancer cell lines induced by ascitic fluids from epithelial ovarian cancer patients NP Alvear‐Hernandez, VI Hernández‐Ramírez, JC Villegas‐Pineda, ... Cell Biology International 48 (5), 610-625, 2024 | | 2024 |
| Half-dose olaparib reduction: Safe and efficient dose in multi-treated Mexican ovarian cancer patients. D Gallardo-Rincon, G Alamilla, E Montes-Servín, D Michel-Tello, ... Journal of Clinical Oncology 37 (15_suppl), e17101-e17101, 2019 | | 2019 |
| Clinical benefit of bevacizumab in Mexican ovarian cancer patients according to the intention of treatment by the oncologist. D Gallardo-Rincon, A Bahena-Gonzalez, E Montes-Servín, ... Journal of Clinical Oncology 37 (15_suppl), e17097-e17097, 2019 | | 2019 |
| Experience with the use of olaparib in patients with ovarian cancer D Gallardo-Rincón, G Alamilla-García, E Montes-Servín, ... Gac Med Mex 155, 541-545, 2019 | | 2019 |
| Immunological evaluation of peptides in pediatric medulloblastomas and diffuse intrinsic pontine glioma (DIPG). JP Marquez-Manriquez, JC Villegas-Pineda, AT Leyva, LM Fernandez, ... Journal of Clinical Oncology 36 (15_suppl), e14066-e14066, 2018 | | 2018 |
Sergio Encarnación Investigador Titular, Centro de Ciencias Genómicas, UNAM在 ccg.unam.mx 的电子邮件经过验证
Sergio Encarnación Investigador Titular, Centro de Ciencias Genómicas, UNAM在 ccg.unam.mx 的电子邮件经过验证